Group One Trading’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-100
Closed -$17K 9167
2021
Q2
$17K Buy
+100
New +$16.7K ﹤0.01% 7301
2020
Q2
Sell
-500
Closed -$46.5K 6415
2020
Q1
$42K Buy
+500
New +$48.8K ﹤0.01% 3826
2019
Q3
Sell
-1,482
Closed -$147K 5762
2019
Q2
$147K Buy
1,482
+482
+48% +$46K ﹤0.01% 3066
2019
Q1
$110K Buy
1,000
+900
+900% +$94.1K ﹤0.01% 3111
2018
Q4
$9K Sell
100
-1,900
-95% -$192K ﹤0.01% 4322
2018
Q3
$220K Buy
+2,000
New +$208K ﹤0.01% 2953
2017
Q4
Sell
-800
Closed -$61K 5412
2017
Q3
$61K Sell
800
-1,213
-60% -$91.7K ﹤0.01% 3537
2017
Q2
$151K Buy
+2,013
New +$140K ﹤0.01% 2846
2016
Q1
Sell
-600
Closed -$25.4K 5139
2015
Q4
$27K Buy
+600
New +$25.2K ﹤0.01% 3766

Other funds holding PRAH

Group One Trading's PRAH Position: Q3 2021 in Review

Group One Trading sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 100 shares — an estimated $17K sold.

Group One Trading first reported a position in PRAH in Q4 2015 and held it in 9 quarters. The position peaked at $220K in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Group One Trading reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Group One Trading sold 100 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $17K.
  • Group One Trading first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 9 quarters.
  • Group One Trading's PRA Health Sciences, Inc. position peaked at $220K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.